Rituximab-induced hypogammaglobulinemia and intravenous immunoglobulin replacement therapy do not protect against relapse in granulomatous with polyangiitis
Permanent lenke
https://hdl.handle.net/10037/10323Dato
2016-08-10Type
Journal articleTidsskriftartikkel